Annual Revenue (£)

Immunocore revenue was $30.11 m in FY, 2020

FY, 2018FY, 2019FY, 2020
Revenue£23.65 m£25.67 m$30.11 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Immunocore revenue breakdown by business segment: 22.4% from GlaxoSmithKline, 74.4% from Genentech and 3.2% from Other

Immunocore revenue breakdown by geographic segment: 22.4% from United Kingdom and 77.6% from United States

FY, 2018FY, 2019
GlaxoSmithKline£6.08 m£5.75 m
Eli Lilly£8.56 m£819 k
Genentech£1.46 m£19.1 m
MedImmune£7.55 m
FY, 2018FY, 2019
United Kingdom£6.08 m£5.75 m
United States£17.58 m£19.92 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu